BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15222252)

  • 1. [Endothelin system and heart failure: a potential therapeutic target].
    Vaz-da-Silva M; Abreu-Lima C
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II81-93. PubMed ID: 15222252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelins in congestive heart failure.
    Moe GW; Rouleau JL; Nguyen QT; Cernacek P; Stewart DJ
    Can J Physiol Pharmacol; 2003 Jun; 81(6):588-97. PubMed ID: 12839270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelin in heart function in health and disease.
    Golfman LS; Hata T; Beamish RE; Dhalla NS
    Can J Cardiol; 1993 Sep; 9(7):635-53. PubMed ID: 8221363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelins: an overview of recent achievements.
    Gensini GF; Conti AA; Prisco D
    Ann Ital Med Int; 1998; 13(2):88-92. PubMed ID: 9734141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin antagonists for chronic heart failure: do they have a role?
    Cowburn PJ; Cleland JG
    Eur Heart J; 2001 Oct; 22(19):1772-84. PubMed ID: 11549299
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting heart failure therapeutics: a historical perspective.
    Murphy GA; Fiuzat M; Bristow MR
    Heart Fail Clin; 2010 Jan; 6(1):11-23. PubMed ID: 19945056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The endothelin peptide system: mechanisms of cardiovascular pathology].
    Gomazkov OA
    Vopr Med Khim; 1999; 45(4):290-303. PubMed ID: 10547878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials of endothelin antagonists in heart failure: a question of dose?
    Kelland NF; Webb DJ
    Exp Biol Med (Maywood); 2006 Jun; 231(6):696-9. PubMed ID: 16740982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current therapeutic approach to chronic heart failure.
    Ghio S; Magrini G; Monti L
    Ital Heart J; 2003 May; 4 Suppl 2():7S-14S. PubMed ID: 14635364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have heart failure.
    Hedrich O; Finley J; Konstam MA; Udelson JE
    Heart Fail Clin; 2005 Apr; 1(1):103-27. PubMed ID: 17386838
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on endothelin.
    Stewart D
    Can J Cardiol; 1998 Jul; 14 Suppl D():11D-13D. PubMed ID: 9713420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of left ventricular remodeling: role of the endothelin pathway.
    Teerlink JR
    J Card Fail; 2002 Dec; 8(6 Suppl):S494-9. PubMed ID: 12555164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the cardiac endothelin system in heart failure.
    Zolk O; Böhm M
    Nephrol Dial Transplant; 2000 Jun; 15(6):758-60. PubMed ID: 10831623
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutral endopeptidase inhibitors and endothelin antagonists.
    Iyengar S; Abraham WT
    Cardiol Clin; 2008 Feb; 26(1):41-8, vi. PubMed ID: 18312904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts of neurohormonal activation in heart failure: mediators and mechanisms.
    Lee CS; Tkacs NC
    AACN Adv Crit Care; 2008; 19(4):364-85; quiz 386-7. PubMed ID: 18981739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of endothelin in the physiology and pathophysiology of airways].
    Faisy C; Naline E; Diehl JL; Chinet T; Advenier C
    Rev Mal Respir; 2002 Jun; 19(3):341-55. PubMed ID: 12161701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drug therapies for the management of acute decompensated heart failure.
    Tunuguntla A
    Tenn Med; 2007 Nov; 100(11):33-7. PubMed ID: 18072692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of endothelin receptor modulators: lessons from human clinical trials.
    Aubert JD; Juillerat-Jeanneret L
    Expert Opin Ther Targets; 2009 Sep; 13(9):1069-84. PubMed ID: 19659448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin system: the double-edged sword in health and disease.
    Kedzierski RM; Yanagisawa M
    Annu Rev Pharmacol Toxicol; 2001; 41():851-76. PubMed ID: 11264479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.